A Peek Into The Market Before The Trading Starts
Pre-open movers US stock futures are lower this morning, ahead of jobless claims data. Futures for the Dow Jones Industrial Average dropped 33 points to 12,730.00 and S&P 500 index futures fell 4.70 points to 1,337.50. Nasdaq 100 futures declined 3.25 points to 2,554.25.
A Peek Into Global Markets European markets were lower today. The STOXX Europe 600 Index declined 0.68%, London's FTSE 100 Index moved down 0.73%, French CAC 40 index fell 0.60% and German DAX 30 index dropped 1.03%.
Asian markets ended lower, with Japan's Nikkei Stock Average declining 0.24%, China's Shanghai Composite dropping 0.42% and Australia's S&P/ASX 200 moving down 1.62%. Hong Kong's Hang Seng index declined 0.41% and India's Sensex fell 0.27%.
Broker Recommendation Analysts at Jefferies upgraded Expeditors International of Washington (NASDAQ: EXPD) from “hold” to “buy.” The target price for Expeditors International of Washington has been raised from $45 to $53.
Expeditors International of Washington shares gained 0.45% to $42.67 in pre-market trading.
- SEI Investments Co (NASDAQ: SEIC) announced today that it has acquired assets of the technology firm NorthStar Systems International, Inc. in a move designed to quickly expand SEI's front-office capabilities across its Global Wealth Platform, the company's new wealth processing platform. To read the full news, click here.
- Jingwei International Limited (NASDAQ: JNGW) today announced its intent to accept a "going private" proposal proposed by Mr. George (Jianguo) Du, Chairman and CEO of the Company, and cease its public company status. To read the full news, click here.
- PMFG Inc (NASDAQ: PMFG) today announced the pricing of its previously announced public offering of 2,600,000 shares of its common stock at a price to the public of $16.00 per share. To read the full news, click here.
- Illumina Inc (NASDAQ: ILMN) announced today that Magistrate Judge Elizabeth D. Laporte of the U.S. District Court for the Northern District of California issued a Claim Construction Order in the litigation brought by Illumina against Complete Genomics, Inc. To read the full news, click here.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.